Goldentree Asset Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,750,000
Closed -$38.5M 43
2020
Q4
$38.5M Sell
1,750,000
-960,000
-35% -$17.9M 1.51% 12
2020
Q3
$54.8M Buy
2,710,000
+960,000
+55% +$16.5M 4.7% 8
2020
Q2
$38.5M Buy
1,750,000
+1,454,200
+492% +$25.6M 4.72% 5
2020
Q1
$7.39M Sell
295,800
-214,500
-42% -$5.17M 1.37% 15
2019
Q4
$12.8M Sell
510,300
-2,009,800
-80% -$52.2M 1.9% 14
2019
Q3
$63M Buy
2,520,100
+1,061,700
+73% +$24.3M 9.11% 2
2019
Q2
$37.9M Sell
1,458,400
-899,600
-38% -$21.4M 4.29% 6
2019
Q1
$61.3M Buy
2,358,000
+1,308,000
+125% +$31.2M 6.62% 6
2018
Q4
$23.6M Sell
1,050,000
-750,000
-42% -$17.8M 3.73% 13
2018
Q3
$40.5M Buy
+1,800,000
New +$41.2M 2.58% 7

Other funds holding BHC

Goldentree Asset Management's BHC Position: Q1 2026 in Review

Goldentree Asset Management held its Bausch Health (BHC) position steady in Q1 2026 at 34,665,731 shares worth $187M. The position accounts for 11.09% of the portfolio, ranked #1.

Goldentree Asset Management first reported a position in BHC in Q1 2018 and has held it in 33 quarters since. The position peaked at $293M in Q1 2024. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Goldentree Asset Management held 34,665,731 shares of Bausch Health worth $187M as of Q1 2026.
  • Goldentree Asset Management left its Bausch Health share count unchanged in Q1 2026.
  • Bausch Health made up 11.09% of Goldentree Asset Management's portfolio in Q1 2026, its #1 holding.
  • Goldentree Asset Management first reported a position in Bausch Health in Q1 2018 and has held it in 33 quarters since.
  • Goldentree Asset Management's Bausch Health position peaked at $293M in Q1 2024.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Goldentree Asset Management's 13F filing for Q1 2026, filed 14 May 2026.